Evidence map›Paper›PMID 34829397›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Maxillary Mucormycosis Osteomyelitis in Post COVID-19 Patients: A Series of Fourteen Cases.

Wael M Said Ahmed, Amira M Elsherbini, Nehal M Elsherbiny, Mohamed El-Sherbiny, Nevine I Ramzy, Ahmed F Arafa

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Post-COVID-19 Jaw Osteonecrosis: A Narrative Review.Medicina (Kaunas, Lithuania) · 2026
    Review
  3. Review
  4. Article
  5. Atypical clinical features of post COVID-19 mucormycosis: A case series.Clinical and experimental dental research · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Management of frontal sinus fungal osteomyelitis in the COVID 19 era: A case series.Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2022
    Review
  10. Atypical presentations of fungal osteomyelitis during post COVID-19 outbreak - Case series.Journal of oral and maxillofacial surgery, medicine, and pathology · 2022
    Article
  11. COVID-Associated Avascular Necrosis of the Maxilla-A Rare, New Side Effect of COVID-19.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2022
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Wael M Said AhmedOral and Maxillofacial Department, Faculty of Dentistry, Mansoura University, Mansoura 35516, Egypt.
Amira M ElsherbiniOral Biology Department, Faculty of Dentistry, Mansoura University, Mansoura 35516, Egypt.
Nehal M ElsherbinyDepartment of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.ORCID 0000-0001-5167-3377
Mohamed El-SherbinyDepartment of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh 71666, Saudi Arabia.ORCID 0000-0002-0814-1743
Nevine I RamzyPathology Department, Faculty of Medicine, Cairo University, Giza 11562, Egypt.
Ahmed F ArafaOral and Maxillofacial Department, Zagazig University, Zagazig 44519, Egypt.
Mansoura University · EGAlfaisal University · SACairo University · EGZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the current pandemic of COVID-19, numerous manifestations and complications have developed. Patients with COVID-19 are at high risk of fungal infections, such as mucormycosis, that may result directly from COVID-19 infection and/or as a side effect of the drugs used in COVID-19 treatment protocol, such as dexamethasone, hydroxychloroquine, and antibiotics. In this report, we described a series of 14 cases with maxillary mucormycosis osteomyelitis in immediate post-COVID-19 patients.

Indexed as

COVID-19maxillamucormycosisosteomyelitis

Identifiers

PMID34829397
PMCPMC8624954
OpenAlexW3209844357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.